| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/10/2005 | WO2005012338A1 Antigenic peptides of sars coronavirus and uses thereof |
| 02/10/2005 | WO2005012337A2 Antigenic peptides of sars coronavirus and uses thereof |
| 02/10/2005 | WO2005012330A2 AMYLOID β-PEPTIDE AND METHODS OF USE |
| 02/10/2005 | WO2005011742A1 Method of treating hepatocellular carcinoma |
| 02/10/2005 | WO2005011734A2 Composition of a vegf antagonist and an anti-proliferative agent and its use for the treatment of cancer |
| 02/10/2005 | WO2005011733A1 Hybrid toxins comprising shiga-like toxin subunits fused to escherichia coli heat labile enterotoxin subunits and vaccines thereof |
| 02/10/2005 | WO2005011732A2 Rabbit bacterium and uses thereof |
| 02/10/2005 | WO2005011730A1 Microsome vaccine |
| 02/10/2005 | WO2005011729A1 Human prostate cell lines in cancer treatment |
| 02/10/2005 | WO2005011723A1 Preventive and/or remedy for hematopoietic tumor |
| 02/10/2005 | WO2005011614A2 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-ige antibody for treatment of asthma or chronic obstructive pulmonary disease |
| 02/10/2005 | WO2005011605A2 Combination therapies for multiple sclerosis |
| 02/10/2005 | WO2005011590A2 Compositions and methods for restoring sensitivity to treatment with her2 antagonists |
| 02/10/2005 | WO2005011580A2 Compositions and methods for herpes simplex prophylaxis and treatment |
| 02/10/2005 | WO2005011571A2 Hepatitis virus core proteins as vaccine platforms and methods of use thereof |
| 02/10/2005 | WO2005004893A3 Inhibition of stress-induced ligand-dependent egfr activation |
| 02/10/2005 | WO2005000345A3 Immunization method against neisseria meningitidis serogroups a and c |
| 02/10/2005 | WO2004111249A3 Protein constructs containing caspase recognition sites |
| 02/10/2005 | WO2004111081A3 Antigenic peptides of sars coronavirus and uses thereof |
| 02/10/2005 | WO2004110480A3 Polyanionic polymer adjuvants for haemophilus influenza b saccharide vaccines |
| 02/10/2005 | WO2004103401A3 Avian combination-vaccine against e.coli and salmonella |
| 02/10/2005 | WO2004094462A3 Methods of peptide preparation |
| 02/10/2005 | WO2004093903A3 Methods and compositions for immunomodulation using cd1 antigens |
| 02/10/2005 | WO2004073652A3 Powder formulations of recombinant staphylococcal enterotoxin b (rseb) made by atmospheric spray-freeze drying for improved vaccination |
| 02/10/2005 | WO2004058188A3 Vaccine compositions and methods |
| 02/10/2005 | WO2004058050A3 Amplified cancer target genes useful in diagnosis and therapeutic screening |
| 02/10/2005 | WO2004043332A3 Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases |
| 02/10/2005 | WO2004024068A3 Novel composition and methods for the treatment of immune related diseases |
| 02/10/2005 | WO2003086175A8 Compositions and methods for the therapy and diagnosis of lung cancer |
| 02/10/2005 | WO2003030624A3 Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof |
| 02/10/2005 | WO2002020718A3 Osteoclast-associated receptor |
| 02/10/2005 | US20050034175 Immune cloning and uses thereof |
| 02/10/2005 | US20050033042 Nucleic acids encoding recominant 56 and 82 kda antigens fromn gametocytes of eimeria maxima and their uses |
| 02/10/2005 | US20050033034 Anti-t cell immunotoxin fusion protein and its therapeutic use |
| 02/10/2005 | US20050033028 Reducing immunogenicities of immunoglobulins by framework-patching |
| 02/10/2005 | US20050033026 Immunoconjugates for the treatment of tumours |
| 02/10/2005 | US20050033025 Human papilloma viral proteins fragments for use in generating immunoglobullins for treatment and prevention infection; immunotherapeutics and diagnostice; viricides |
| 02/10/2005 | US20050033023 Immunostimulatory parathyroid hormone-related peptide (PTH-rP) for use in diagnosis, prevention and treatment of cell proliferative disorders; tissue targeted therapy |
| 02/10/2005 | US20050033022 Fusion proteins comprising HIV-1 Tat and/or Nef proteins |
| 02/10/2005 | US20050032978 Copolymer of isobutylene with carbamate groups which is curable |
| 02/10/2005 | US20050032817 Kinesin spindle protein (KSP) inhibitors, e.g., 3-benzyl-2-(1-{(4-bromobenzyl)[2-(dimethylamino)ethyl]amino}propyl)furo[2,3-d]pyrimidin-4(3H)-one; antiproliferative and -carcinogenic agents; side effects reduction; cancers of the brain, genitourinary tract, lymphatic system, stomach, larynx and lung |
| 02/10/2005 | US20050032759 administering to humans synergystic mixtures of aromatase inhibitors and epidermal growth factor receptor antagonists as antitumor agents |
| 02/10/2005 | US20050032736 Immunostimulatory nucleic acid molecules |
| 02/10/2005 | US20050032734 Vectors and methods for immunization or therapeutic protocols |
| 02/10/2005 | US20050032732 DNA vaccine expressing HA1 of equine-2 influenza virus |
| 02/10/2005 | US20050032730 Pharmaceutical composition containing a stabilised mRNA optimised for translation in its coding regions |
| 02/10/2005 | US20050032714 immunotherapeutic for therapy and prophylaxis of cancer; reduced duration, less toxicity, and as thus results in improved tolerance |
| 02/10/2005 | US20050032699 Composition of a VEGF antagonist and an anti-proliferative agent |
| 02/10/2005 | US20050032693 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization |
| 02/10/2005 | US20050032691 Methods for treating glaucoma |
| 02/10/2005 | US20050032222 Modified viral particles with immunogenic properties and reduced lipid content useful for treating and preventing infectious diseases |
| 02/10/2005 | US20050032217 Transforming lymphocytes with vector comprising gene sequences which code cytolethal distending toxin (cdt), leukotoxins and heat shock protein and generating regulatory cell which can be used to treat and/or prevent transplant rejection, autoimmune and inflammatory diseases; immunotherapy |
| 02/10/2005 | US20050032216 Plasmid comprising antibody specific for cell surface membrane protein receptor (5T4) for use in tissue directed treatment of tumors; tissue targeted therapy |
| 02/10/2005 | US20050032174 Multimeric protein for use in the treatment and prevention of infection and bleeding disorders |
| 02/10/2005 | US20050032170 Expression vector comprising nucleotide sequences coding native sequence-4 (NS4) for use in identifying modulators for treatment and prevention of obesity, cachexia and anorexia |
| 02/10/2005 | US20050032168 17 human secreted proteins |
| 02/10/2005 | US20050032164 IL4 receptor antagonists for horse, dog and cat |
| 02/10/2005 | US20050032161 Novel xanthine phosphoribosyl transferase |
| 02/10/2005 | US20050032155 Expression vector comprising nucleotide sequences coding defective receptor protein for use as model in treatment and prevention of convulsive disorders |
| 02/10/2005 | US20050032134 Neoplasm-specific polypeptides and their uses |
| 02/10/2005 | US20050032103 Nucleic acids and polypeptides specific for pathogenic strains of the Neisseria genus |
| 02/10/2005 | US20050032101 Methods for diagnosis and therapy of cancer and composition useful therein |
| 02/10/2005 | US20050032047 Comprises peptide for genotyping and detecting hepatitis viral infection; immunoassay |
| 02/10/2005 | US20050032044 Lipid and cryoprotectant; gene therapy |
| 02/10/2005 | US20050032043 Recombinant negative strand RNA virus expression systems and vaccines |
| 02/10/2005 | US20050032039 HIV-specific T-cell induction |
| 02/10/2005 | US20050031649 Bacillus Calmette Guerin (BCG) heat shock protein; treating breast cancer, ovarian cancer, colon cancer, prostate cancer and lung cancer |
| 02/10/2005 | US20050031646 Immunogens; polysaccharide conjugate antigens derived from pathogenic bacterium conjugated to protein D from Haemophilus influenzae |
| 02/10/2005 | US20050031644 Modifying wild strain of enteroinvasive Shigella; cannot spread within infected cells and from infected to uninfected cells of the host; vaccines; deactivation by inserting transposon into gene; mutagenizing; genetically engineered by allelic exchange |
| 02/10/2005 | US20050031643 Microorganisms for therapy |
| 02/10/2005 | US20050031641 Recombinant vaccine against West Nile Virus |
| 02/10/2005 | US20050031640 Vaccination and immunotherapy as new therapeutic modalities in the treatment of glaucoma |
| 02/10/2005 | US20050031639 Materials and methods for immunizing against FIV infection |
| 02/10/2005 | US20050031638 Vaccine |
| 02/10/2005 | US20050031637 Fusion protein from a protein of papillomaviruses and E protein of one or more papillomaviruses and/or excipients; the fusion protein contains no papillomavirus-unspecific epitopes; treating tumors of the larynx, cervix, penis, vulva or anus |
| 02/10/2005 | US20050031636 Papilloma virus capsomere vaccine formulations and methods of use |
| 02/10/2005 | US20050031635 Inducing specific B cell anergy to an immunogen comprising a conjugate of a nonimmunogenic valency platform molecule and an analog of the immunogen that (a) binds specifically to B cells to which the immunogen binds and (b) lacks the T cell epitope(s) of the immunogen |
| 02/10/2005 | US20050031634 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 02/10/2005 | US20050031633 Glucan binding protein and glucosyltransferase immunogens |
| 02/10/2005 | US20050031630 Immunogen (antibody determinant, lipid, peptide, and/or carbohydrate) derived from virus/cancer cell with mast cell membrane activator; microbiocides; wound healing agents; reduced scarring |
| 02/10/2005 | US20050031629 An immunogenic A beta fragment linked to a carrier molecule to form a conjugate, wherein the carrier molecule promotes an immune response comprising antibodies to the A beta fragment; Alzheimer's disease; antibodies |
| 02/10/2005 | US20050031628 Chimeric antigens for breaking host tolerance to foreign antigens |
| 02/10/2005 | US20050031627 Methods for preparing immunoconjugates |
| 02/10/2005 | US20050031620 Combined cancer treatment methods using selected antibodies to aminophospholipids |
| 02/10/2005 | US20050031618 Induction of tolerance by apoptotic and/or necrotic cells |
| 02/10/2005 | US20050031617 Antibodies specific for cancer associated antigen SM5-1 and uses thereof |
| 02/10/2005 | US20050031616 Controlled platelet activation to monitor therapy of ADP antagonists |
| 02/10/2005 | US20050031615 For treating proliferative diseases characterized by neovascularization such as cancer, rheumatoid arthritis, psoriasis, proliferative retinopathy, and/or macular degeneration; rapid prevention of blood clotting via the extrinsic pathway; angiogenesis inhibitors |
| 02/10/2005 | US20050031613 CD 16 antigen; antibody produced by cell unresistant to lectin which recognizes sugar chain in which 1-position of fucose is bound to 6-position of N-acetylglucosamine in the reducing end through alpha -bond in a complex N-glycoside-linked sugar chain; signal transduction |
| 02/10/2005 | US20050031612 Cytotoxic t lymphocytes; human leukocyte antigen; non-hematopoietic cells; graft versus host disease |
| 02/10/2005 | US20050031611 Transplant tolerance by costimulation blockade and T-cell activation-induced apoptosis |
| 02/10/2005 | US20050031610 Formed in presence of extracellular hyaluronan, and contains intracellular gamma-secretase and metalloprotease |
| 02/10/2005 | US20050031609 Compositions for use in treating ige-associated disorders |
| 02/10/2005 | US20050031606 Lyase treatment for P. carinii |
| 02/10/2005 | US20050031592 Methods and compositions for inducing immune responses and protective immunity by priming with alpha virus replicon vaccines |
| 02/10/2005 | US20050031587 Immune response induction method |
| 02/10/2005 | US20050031583 Uses of opg to modulate immune responses |
| 02/10/2005 | US20050031579 Polymer encapsulation of adenoviruses |
| 02/10/2005 | DE10297513T5 In vitro Herstellung von dendritischen Zellen aus CD14+ Monocyten In vitro production of dendritic cells from CD14 + monocytes |
| 02/10/2005 | CA2536120A1 Polymer encapsulation of adenoviruses |